ArticleBlood neoplasia2024

CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib.

Chung Hoow Kok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.